In June 2025, the European Medicines Agency officially recognized NAION as a very rare side effect of semaglutide after reviewing all data, concluding it may affect up to 1 in 10,000 people and recommending product information updates
Wegovy is FDA-approved for long-term weight management in adults who are fat or overweight and who suffer from at least one weight-related illness, such as type 2 diabetes, high blood pressure, or high cholesterol
Oral supplements, while safer in terms of administration, have lower bioavailability unless formulated specifically for enhanced absorption
If youre taking Ozempic, you could potentially experience gastrointestinal side effects such as nausea, vomiting, constipation, diarrhea, or abdominal pain
Through advanced lab testing and personalized analysis, we identify the specific root causes of your metabolic dysfunction so that GLP-1 therapy is part of a targeted solution rather than an isolated intervention
The GLP-1 component slows gastric emptying and reduces appetite through central nervous system signaling